Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marina Cuchel

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Current Atherosclerosis Reports|March 17, 2016
Recent Developments in Gene Therapy for Homozygous Familial HypercholesterolemiaEzim Ajufo, Marina Cuchel
Atherosclerosis|February 1, 2023
Gene editing for dyslipidemias: New tools to "cut" lipidsSylvia Stankov, Marina Cuchel
Current Opinion in Lipidology|April 26, 2020
Homozygous familial hypercholesterolemia: what treatments are on the horizon?Archna Bajaj, Marina Cuchel
The Lancet. Diabetes & Endocrinology|October 7, 2024
Type 2 diabetes in familial hypercholesterolaemia: another look at traditional risk factorsMarina Cuchel, Archna Bajaj
Current Opinion in Lipidology|April 26, 2023
Lipid metabolismFrederick Raal, Marina Cuchel
Journal of Atherosclerosis and Thrombosis|April 25, 2022
Advancements in the Treatment of Homozygous Familial HypercholesterolemiaArchna Bajaj, Marina Cuchel
Arteriosclerosis, Thrombosis, and Vascular Biology|December 28, 2020
Controversial Role of Lecithin:Cholesterol Acyltransferase in the Development of Atherosclerosis: New Insights From an LCAT ActivatorCecilia Vitali, Marina Cuchel
European Heart Journal|July 13, 2022
From supravalvular to valvular aortic stenosis: are statins contributing to the phenotypic shift in homozygous familial hypercholesterolaemia?Archna Bajaj, Marina Cuchel
European Heart Journal|May 11, 2016
Improving the yield of genetic testing in familial hypercholesterolaemiaEzim Ajufo, Marina Cuchel
Circulation|January 29, 2024
LDL-C-Lowering Therapies for Adults and Children With Homozygous Familial Hypercholesterolemia: Challenges and SuccessesRaul D Santos, Marina Cuchel
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Current Atherosclerosis Reports|March 17, 2016
Recent Developments in Gene Therapy for Homozygous Familial HypercholesterolemiaEzim Ajufo, Marina Cuchel
Atherosclerosis|February 1, 2023
Gene editing for dyslipidemias: New tools to "cut" lipidsSylvia Stankov, Marina Cuchel
Current Opinion in Lipidology|April 26, 2020
Homozygous familial hypercholesterolemia: what treatments are on the horizon?Archna Bajaj, Marina Cuchel
The Lancet. Diabetes & Endocrinology|October 7, 2024
Type 2 diabetes in familial hypercholesterolaemia: another look at traditional risk factorsMarina Cuchel, Archna Bajaj
Current Opinion in Lipidology|April 26, 2023
Lipid metabolismFrederick Raal, Marina Cuchel
Journal of Atherosclerosis and Thrombosis|April 25, 2022
Advancements in the Treatment of Homozygous Familial HypercholesterolemiaArchna Bajaj, Marina Cuchel
Arteriosclerosis, Thrombosis, and Vascular Biology|December 28, 2020
Controversial Role of Lecithin:Cholesterol Acyltransferase in the Development of Atherosclerosis: New Insights From an LCAT ActivatorCecilia Vitali, Marina Cuchel
European Heart Journal|July 13, 2022
From supravalvular to valvular aortic stenosis: are statins contributing to the phenotypic shift in homozygous familial hypercholesterolaemia?Archna Bajaj, Marina Cuchel
European Heart Journal|May 11, 2016
Improving the yield of genetic testing in familial hypercholesterolaemiaEzim Ajufo, Marina Cuchel
Circulation|January 29, 2024
LDL-C-Lowering Therapies for Adults and Children With Homozygous Familial Hypercholesterolemia: Challenges and SuccessesRaul D Santos, Marina Cuchel
Pageof 10